SpringLeaf Therapeutics (formerly known as Entra Pharmaceuticals, Inc.) is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on convergent science and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Flybridge Capital Partners and North Bridge Venture Partners.
Funding Rounds (2) - $19MUpdate
Excel Venture Management builds companies that apply transformative life science technologies to...
Early stage venture capital firm
North Bridge Venture Partners is an early-stage venture capital firm based in Boston,...
8 St. Mary's Street
Boston, MA 02215